ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 2604

$530K Total Retail Price of All Prescriptions

Rank: 175 out of 2604

277 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 277 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 277 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,836 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
FUROSEMIDE 574 531 1 8
HYDROCODONE-ACETAMINOPHEN 439 312 S3 2 1
LISINOPRIL 403 315 3 3
LEVOTHYROXINE SODIUM 403 391 3 4
SIMVASTATIN 361 302 5 2
POTASSIUM CHLORIDE 317 296 6 16
METOPROLOL TARTRATE 308 265 7 9
AMLODIPINE BESYLATE 295 263 8 6
OMEPRAZOLE 275 234 9 5
TRAMADOL HCL 222 205 10 15
DONEPEZIL HCL 217 217 11 28
WARFARIN SODIUM 216 197 12 13
CITALOPRAM HBR 200 194 13 18
QUETIAPINE FUMARATE 168 131 14 66
NAMENDA 166 166 15 37
RISPERIDONE 157 151 16 65
GABAPENTIN 145 113 17 12
CLOPIDOGREL 141 123 18 39
FAMOTIDINE 132 132 19 68
CYMBALTA 123 104 20 44
DIVALPROEX SODIUM 120 95 21 81
FENTANYL 119 119 S2 22 48
MIRTAZAPINE 118 117 23 52
RANITIDINE HCL 113 90 24 25
CARVEDILOL 112 99 25 26
ISOSORBIDE MONONITRATE ER 111 80 26 38
HYDROCORTISONE 97 77 27 161
HYDRALAZINE HCL 96 81 28 85
PANTOPRAZOLE SODIUM 92 74 29 64
ATORVASTATIN CALCIUM 87 68 30 19
TAMSULOSIN HCL 84 75 31 30
TRAZODONE HCL 84 80 31 46
CIPROFLOXACIN HCL 82 76 33 59
ALBUTEROL SULFATE 82 53 33 93
KLOR-CON M20 81 69 35 86
SEROQUEL 81 69 35 149
HYDROCHLOROTHIAZIDE 79 79 37 10
METOPROLOL SUCCINATE 77 77 38 17
ATENOLOL 76 76 39 11
PLAVIX 75 65 40 75
ZOLPIDEM TARTRATE 75 56 40 21
METFORMIN HCL 72 51 42 7
LIDODERM 70 66 43 80
POLYETHYLENE GLYCOL 3350 69 69 44 42
LEVETIRACETAM 65 37 45 96
IBUPROFEN 64 40 46 32
ESCITALOPRAM OXALATE 63 43 47 73
SERTRALINE HCL 62 52 48 23
DIGOXIN 56 56 49 71
PEN NEEDLE 52 50 50 145
NITROFURANTOIN MONO-MACRO 51 49 51 299
NOVOLOG FLEXPEN 50 50 52 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.